Clinical Trial Update: Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating normobaric hyperoxia plus intravenous thrombolysis for acute ischemic stroke with long-term outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• intravenous thrombolysis
• normobaric hyperoxia

Snippet

Sponsor: Ji Xunming,MD,PhD | Conditions: Acute Ischemic Stroke | Phase 3 | Status: UNKNOWN